Sonnet BioTherapeutics HoldingsSONN 
$1.42-1.39%24h
-1.39%24h
Global rank32044
Market cap$1.47M
Change 7d-10.69%
YTD Performance-
SP500 benchmark
P/E-0.08
P/S9.97
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings Revenue data
According to Sonnet BioTherapeutics Holdings latest financial reports the company had revenue of $147.81K in 2023-09-30, a -57.76% decrease from 2022. Sonnet BioTherapeutics Holdings highest revenue was $483.63K in 2021.
Revenue history for Sonnet BioTherapeutics Holdings from 2020 to 2025
-
Value:-
Sonnet BioTherapeutics Holdings revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $147.81K | -57.76% |
| 2022 | $349.94K | -27.64% |
| 2021 | $483.63K | Infinity% |
| 2020 | $0 | - |
View the top revenue stocks 
